Exonicus Overview
- Status
-
Private
- Employees
-
5
- Latest Deal Type
-
Crowdfunding
- (Announced)
- Latest Deal Amount
-
$1.06M
- Investors
-
8
Exonicus General Information
Description
Developer of extended reality (XR) medical training technology designed to create immersive trauma simulations crucial for military and civilian medical professionals. The company develops medical simulators that enable medical personnel to augment their trauma treatment capabilities, allowing physicians to address medical training challenges with the aid of technological advancements, enhance medical preparedness, and improve patient outcomes in critical care scenarios.
Contact Information
Website
exonicus.comCorporate Office
- Fluke Hall, 4000 Mason Road
- Suite 300
- Seattle, WA 98195
- United States
Corporate Office
- Fluke Hall, 4000 Mason Road
- Suite 300
- Seattle, WA 98195
- United States
Exonicus Timeline
Exonicus Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Equity Crowdfunding | 22-May-2025 | $1.06M | Announced | Generating Revenue | ||
| 8. Angel (individual) | 30-May-2025 | Completed | Generating Revenue | |||
| 7. Accelerator/Incubator | 01-Jan-2024 | Completed | Generating Revenue | |||
| 6. Later Stage VC | 31-Oct-2019 | Completed | Generating Revenue | |||
| 5. Later Stage VC | 28-Jun-2018 | Completed | Generating Revenue | |||
| 4. Grant | 23-Mar-2018 | Completed | Generating Revenue | |||
| 3. Seed Round | 12-Jan-2017 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 29-Nov-2016 | $21.6K | $21.6K | Completed | Generating Revenue | |
| 1. University Spin-Out | 01-Jan-2013 | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Exonicus Comparisons
Industry
Financing
Details
Exonicus Competitors (3)
One of Exonicus’s 3 competitors is Oxford Medical Simulation, a Venture Capital-Backed company based in London, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Oxford Medical Simulation | Venture Capital-Backed | London, United Kingdom | ||||
| SimX (Healthcare Devices and Supplies) | Private Equity-Backed | San Francisco, CA | ||||
| UpSkill (USA) | Venture Capital-Backed | Westminster, CO |
Exonicus Signals
Exonicus Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| ASP Asset Management | Venture Capital | Minority | ||
| LatBan | Angel Group | Minority | ||
| Capital Factory | Accelerator/Incubator | Minority | ||
| Alesco Ventures | Venture Capital | Minority | ||
| Horizon 2020 | Government |
Exonicus FAQs
-
Where is Exonicus headquartered?
Exonicus is headquartered in Seattle, WA.
-
What is the size of Exonicus?
Exonicus has 5 total employees.
-
What industry is Exonicus in?
Exonicus’s primary industry is Educational Software.
-
Is Exonicus a private or public company?
Exonicus is a Private company.
-
What is the current valuation of Exonicus?
The current valuation of Exonicus is .
-
What is Exonicus’s current revenue?
The current revenue for Exonicus is .
-
How much funding has Exonicus raised over time?
Exonicus has raised $827K.
-
Who are Exonicus’s investors?
ASP Asset Management, LatBan, Capital Factory, Alesco Ventures, and Horizon 2020 are 5 of 8 investors who have invested in Exonicus.
-
Who are Exonicus’s competitors?
Oxford Medical Simulation, SimX (Healthcare Devices and Supplies), and UpSkill (USA) are competitors of Exonicus.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process